Liminatus Pharma, Inc.
LIMNW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001971387
No open-market purchases or sales by Liminatus Pharma, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $90.1K in total; no superinvestor holds it.
Other share classesLIMN
13F holders, Q4 2025
Institutional positions in Liminatus Pharma, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q3 2025
- Shares held
- 2.46M
- −162.0K (−6.2%) vs. Q3 2025
- Total value
- $95.0K
- −$303.0K (−76.1%) vs. Q3 2025
- New holders
- 2
- 1 more added
- Sold out
- 3
- 5 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIMNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $90.1K |
| Q1 2026 | 21 | $72.6K |
| Q4 2025 | 25 | $95.0K |
| Q3 2025 | 27 | $400.3K |
| Q2 2025 | 26 | $837.0K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Liminatus Pharma, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flow Traders U.S. LLC | 13,110 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 100 | $4 | 0.00% | −100−50.0% | Reduced |
| HGC Investment Management Inc. | 1,250 | $44 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,212 | $147 | 0.00% | +3,922+1,352.4% | Added |
| DuPont Capital Management Corp | 6,250 | $219 | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 12,400 | $434 | 0.00% | +12,400 | New |
| Limestone Investment Advisors LP | 22,562 | $790 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,906 | $837 | 0.00% | +23,906 | New |
| Jane Street Group, LLC | 24,274 | $850 | 0.00% | −153−0.6% | Reduced |
| Arena Capital Advisors, LLC- CA | 29,166 | $1.02K | 0.00% | 00.0% | Unchanged |
| GTS Securities LLC | 29,700 | $1.04K | 0.00% | −300−1.0% | Reduced |
| LMR Partners LLP | 29,961 | $1.05K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 35,100 | $1.23K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 47,500 | $1.73K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 50,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 62,795 | $2.20K | 0.00% | −68−0.1% | Reduced |
| D. E. Shaw & Co., Inc. | 83,353 | $2.92K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 111,745 | $3.91K | 0.00% | 00.0% | Unchanged |
| Moore Capital Management, LP | 125,000 | $4.38K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 122,688 | $4.69K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $5.55K | 0.00% | – | – |
| Saba Capital Management, L.P. | 233,761 | $8.94K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 268,199 | $10.6K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 319,510 | $12.2K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 805,177 | $28.2K | 0.00% | −2000.0% | Reduced |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −97,325−100.0% | Sold out |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −89,098−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |